Source: Annual Congress 2003 - Acute exacerbations of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. V. Yakovleva, A. N. Kokosov (St Petersberg, Russia). Influenza antibodies in patients with COPD. Eur Respir J 2003; 22: Suppl. 45, 2132

Member's Comments

No comment yet.

Related content which might interest you: Influenza and pneumococcal vaccination in patients with COPD Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 Influenza vaccination in COPD Source: International Congress 2019 – Vaccines against respiratory infections Year: 2019 Efficacy of influenza and pneumococcal vaccinations among patients with COPD Source: Annual Congress 2007 - Treatment of COPD Year: 2007 Perception and uptake of the influenza and pneumococcal vaccinations in patients with COPD Source: Annual Congress 2008 - Organisation of care and management of COPD Year: 2008 Antibody response to influenza vaccine in patients with sarcoidosis Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010 Influenza A virus in exacerbation of asthma within scool children Source: Eur Respir J 2003; 22: Suppl. 45, 500s Year: 2003 Clinical characteristics and risk factors of virus or influenza infection among the hospitalized pneumonia in COPD patients Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab Year: 2016 Influenza and pneumococcal vaccines prevalence and their influance on asthma and chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 292s Year: 2005 Detection of antibody response against influenza vaccine in patients with chronic obstructive pulmonary disease (COPD) by quantitative ELISA and evalution of clinical findings Source: Annual Congress 2009 - Viruses and respiratory infections: prevalence and mechanisms of infection Year: 2009 Hospitalizations from pandemic influenza (pH1N1) infections among patients with COPD in Spain Source: Annual Congress 2012 - Epidemiology of various respiratory diseases Year: 2012 Influenza A H1N1 as a risk for asthma in children Source: Annual Congress 2010 - Paediatric epidemiology: infection, prematurity and congenital abnormalities Year: 2010 Prevalance of chlamydia, mycoplasma, legionella and influenza A antibodies in acute exacerbation of COPD Source: Eur Respir J 2001; 18: Suppl. 33, 484s Year: 2001 Can the influenza vaccine response be predicted in COPD patients by clinical parameters? Source: International Congress 2015 – Treatment and control of respiratory disease Year: 2015 Evolution of influenza vaccination coverages in Spanish patients with asthma or chronic bronchitis Source: Eur Respir J 2004; 24: Suppl. 48, 144s Year: 2004 Association between respiratory viruses and exacerbations in COPD patients Source: Annual Congress 2010 - Genetics and risk factors for asthma and COPD Year: 2010 Respiratory syncytial virus (RSV) disease in hospitalised adults in Europe with COPD: Impact of GOLD score on RSV disease burden Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease Year: 2018 Relationship of cold frequency and virus detection to exacerbations in COPD patients Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015 Hospitalizations from pandemic influenza (pH1N1) infections among patients with asthma in Spain Source: Annual Congress 2012 - Epidemiology of various respiratory diseases Year: 2012 Comparison of efficacy of grippe vaccination and broncho vaxom administration in COPD patients Source: International Congress 2015 – Different data in COPD Year: 2015 Respiratory disease in a cohort of patients with primary antibody deficiency Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019